Microbix Biosystems Inc.
MBX.TO
TSX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -19.74% | 11.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -19.74% | 11.32% | |||
| Cost of Revenue | -29.44% | 10.27% | |||
| Gross Profit | -5.84% | 12.85% | |||
| SG&A Expenses | 7.97% | -8.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.99% | -0.88% | |||
| Operating Income | -33.31% | 33.34% | |||
| Income Before Tax | -22.85% | 24.95% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -22.85% | 22.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -22.85% | 22.12% | |||
| EBIT | -33.31% | 33.34% | |||
| EBITDA | -35.09% | 43.46% | |||
| EPS Basic | -23.33% | 24.05% | |||
| Normalized Basic EPS | -21.05% | 25.49% | |||
| EPS Diluted | -23.33% | 25.93% | |||
| Normalized Diluted EPS | -21.05% | 25.49% | |||
| Average Basic Shares Outstanding | -0.28% | 2.08% | |||
| Average Diluted Shares Outstanding | -0.24% | 2.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||